NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Device for Monitoring Pain During Intraoperative, Pre/Post Surgical Periods: Comparison With Standard of Care Monitoring

Not Applicable

Terminated

Conditions: Assessment, Pain
Pain Measurement

Interventions: Other: These patients receive the Baeta device and take it home

First Posted Date: 2015-12-15

Last Posted Date: 2017-07-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02630134

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

Not Applicable

Completed

Conditions: Smoking
Tobacco Use Disorder

Interventions: Device: e-cigarettes

First Posted Date: 2015-12-11

Last Posted Date: 2020-02-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT02628964

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Sleep Health Education and Social Support Among Blacks With OSA

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Behavioral: Attention Control Group
Behavioral: Peer Based Sleep Health Education and Social Support

First Posted Date: 2015-12-11

Last Posted Date: 2021-07-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1092

Registration Number: NCT02628977

Locations: 🇺🇸
180 Madison Ave, New York, New York, United States

A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

Phase 2

Withdrawn

Conditions: HSAN Type IV

Interventions: Drug: Droxidopa (L-DOPS)
Drug: Placebo

First Posted Date: 2015-12-08

Last Posted Date: 2016-09-12

Lead Sponsor: NYU Langone Health

Registration Number: NCT02624310

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

Phase 2

Active, not recruiting

Conditions: Muscle-invasive Urothelial Cancer of the Bladder

Interventions: Biological: Pembrolizumab
Procedure: Transurethral Resection of Bladder Tumor
Drug: Gemcitabine
Radiation: External Beam Radiation Therapy

First Posted Date: 2015-12-03

Last Posted Date: 2024-10-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT02621151

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering, New York, New York, United States

and more 2 locations

Cognitive Detection of Preclinical AD: Validation Using Biomarkers

Completed

Conditions: Mild Cognitive Impairment

First Posted Date: 2015-11-30

Last Posted Date: 2021-01-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 81

Registration Number: NCT02616679

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis

Not Applicable

Completed

Conditions: Oral Cancer
Oral Mucositis

Interventions: Procedure: Standard of Care Oral Hygiene Instructions
Procedure: Oral Mucosa Deterging and Periodontal Debridement (OMDP)
Procedure: Dental scaling, ultrasonic
Other: Chlorhexidine

First Posted Date: 2015-11-20

Last Posted Date: 2020-08-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT02608879

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia

Phase 2

Withdrawn

Conditions: Vomiting
Familial Dysautonomia
Nausea

Interventions: Other: Placebo
Drug: Dronabinol

First Posted Date: 2015-11-20

Last Posted Date: 2019-06-13

Lead Sponsor: NYU Langone Health

Registration Number: NCT02608931

Locations: 🇺🇸
NYU Medical Center, New York, New York, United States

Neurotrack Test Validation Protocol

Completed

Conditions: Mild Cognitive Impairment

First Posted Date: 2015-11-18

Last Posted Date: 2019-12-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 81

Registration Number: NCT02608021

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Radiation: Accelerated intensity modulated radiation therapy (AIMRT)

First Posted Date: 2015-11-17

Last Posted Date: 2020-08-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 314

Registration Number: NCT02606708

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy